SCHEMBL8801039

SCHEMBL8801039

CCOC(=O)C(CCSc1ccccc1)(CCC(N)C(=O)OC(C)(C)C)C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.39
ALDH1A1 P00352 4/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
AAK1 Q2M2I8 1/20 0.35
HPGD P15428 1/20 0.35
PIN1 Q13526 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
KIF11 P52732 7/20 0.34
MMP8 P22894 1/20 0.34
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5428506 0.83 ALDH1A1 (0.50) ALDH1A1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL8801034 0.77 IDO1 (0.46) ALDH1A1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL8801044 0.77 ALDH1A1 (0.40) ALDH1A1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL7445938 0.77 ALDH1A1 (0.49) ALDH1A1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL8633545 0.76 SLC7A5 (0.43) LTA4HALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL8329546 0.76 LTA4H (0.52) LTA4HALDH1A1MAPTSMN1; SMN2AAK1
SCHEMBL8803290 0.75 LTA4H (0.46) LTA4HALDH1A1SMN1; SMN2AAK1MMP8
SCHEMBL28545211 0.73 KIF11 (0.40) LTA4HNPC1RAB9AAAK1PIN1
SCHEMBL8799063 0.73 LTA4H (0.45) LTA4HSMN1; SMN2LMNAMMP8
SCHEMBL8633149 0.71 CYP4F2 (0.36) LTA4HAAK1MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed